Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
APG-2449
i
Other names:
APG-2449, APG 2449
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Ascentage Pharma
Drug class:
ALK inhibitor, Multi-tyrosine kinase inhibitor, ROS1 inhibitor, FAK inhibitor
Related drugs:
‹
crizotinib (312)
entrectinib (178)
alectinib (104)
lorlatinib (94)
ceritinib (67)
brigatinib (50)
ensartinib (42)
repotrectinib (27)
iruplinalkib (11)
TAE-684 (9)
SAF-189 (7)
TQ-B3101 (6)
TPX-0131 (4)
envonalkib (3)
TGRX-326 (3)
AZD3463 (2)
NVL-655 (1)
SY-707 (1)
SY-3505 (1)
ALK inhibitor (0)
ASP-3026 (0)
CEP-37440 (0)
TY-2136b (0)
ZG0418 (0)
TSR-011 (0)
XZP-3621 (0)
sorafenib (180)
anlotinib (139)
ponatinib (98)
pazopanib (76)
gilteritinib (75)
cabozantinib tablet (74)
regorafenib (65)
midostaurin (51)
vandetanib (26)
cabozantinib capsule (24)
nintedanib (18)
TT-00420 (16)
SHR 1020 (5)
MGCD516 (5)
AEE788 (4)
donafenib (2)
AMG 706 (2)
HA121-28 (1)
CT053PTSA (1)
sorafenib nanoparticle (0)
masitinib (0)
TSN084 (0)
TAS-115 (0)
SIM1803-1A (5)
AB-106 (5)
AGX87 (0)
XZP-5955 (0)
NVL-520 (0)
VS-6063 (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
IN10018 (3)
GSK2256098 (1)
PF-562271 (1)
FAK-JAK 2 dual Inhib (0)
NVP-TAE226 (0)
PF-573228 (0)
crizotinib (312)
entrectinib (178)
alectinib (104)
lorlatinib (94)
ceritinib (67)
brigatinib (50)
ensartinib (42)
repotrectinib (27)
iruplinalkib (11)
TAE-684 (9)
SAF-189 (7)
TQ-B3101 (6)
TPX-0131 (4)
envonalkib (3)
TGRX-326 (3)
AZD3463 (2)
NVL-655 (1)
SY-707 (1)
SY-3505 (1)
ALK inhibitor (0)
ASP-3026 (0)
CEP-37440 (0)
TY-2136b (0)
ZG0418 (0)
TSR-011 (0)
XZP-3621 (0)
sorafenib (180)
anlotinib (139)
ponatinib (98)
pazopanib (76)
gilteritinib (75)
cabozantinib tablet (74)
regorafenib (65)
midostaurin (51)
vandetanib (26)
cabozantinib capsule (24)
nintedanib (18)
TT-00420 (16)
SHR 1020 (5)
MGCD516 (5)
AEE788 (4)
donafenib (2)
AMG 706 (2)
HA121-28 (1)
CT053PTSA (1)
sorafenib nanoparticle (0)
masitinib (0)
TSN084 (0)
TAS-115 (0)
SIM1803-1A (5)
AB-106 (5)
AGX87 (0)
XZP-5955 (0)
NVL-520 (0)
VS-6063 (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
IN10018 (3)
GSK2256098 (1)
PF-562271 (1)
FAK-JAK 2 dual Inhib (0)
NVP-TAE226 (0)
PF-573228 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
ROS1 positive
Mesothelioma
ROS1 positive
Mesothelioma
APG-2449
Sensitive: C2 – Inclusion Criteria
APG-2449
Sensitive
:
C2
APG-2449
Sensitive: C2 – Inclusion Criteria
APG-2449
Sensitive
:
C2
ALK positive
Mesothelioma
ALK positive
Mesothelioma
APG-2449
Sensitive: C2 – Inclusion Criteria
APG-2449
Sensitive
:
C2
APG-2449
Sensitive: C2 – Inclusion Criteria
APG-2449
Sensitive
:
C2
ROS1 positive
Non Small Cell Lung Cancer
ROS1 positive
Non Small Cell Lung Cancer
APG-2449
Sensitive: C2 – Inclusion Criteria
APG-2449
Sensitive
:
C2
APG-2449
Sensitive: C2 – Inclusion Criteria
APG-2449
Sensitive
:
C2
ALK positive
Non Small Cell Lung Cancer
ALK positive
Non Small Cell Lung Cancer
APG-2449
Sensitive: C2 – Inclusion Criteria
APG-2449
Sensitive
:
C2
APG-2449
Sensitive: C2 – Inclusion Criteria
APG-2449
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login